Table 1 Data sets

Alizadeh [13]

Diffuse large B-cell lymphoma (DL-BCL) and other lymphoid malignancies (FL and CLL), normal cell samples as well as tissue type cell lines.

http://llmpp.nih.gov/lymphoma,

GEO: GSE60

133 × 7806

(133 × 7430)

DLCL (68) and other (65) samples (FL, CLL, normal cell samples and a variety of cell lines).

Finak [14]

Samples from epithelial and striomal tissue from breast reduction tissue from tumor-adjacent normal tissue. Agilent microarrays.

GEO: GSE4823

66 × 33491

epithelial (34) and stromal tissue (32)

Galland [15]

40 non-functioning pituitary adenomas (NFPAs). Agilent microarrays.

arrayExpress: E-TABM-899

40 × 40475

(40 × 40291)

invasive (22) and non-invasive (18)

Herschkowitz [16]

Human breast tumor samples (The full study includes 232 samples, but here only 119 samples run on a particular array (GPL1390) are included).

GEO: GSE3165

106 × 19718

ER-status, ER+ (59) and ER- (47)

Jones [17]

High-grade lung neuroendocrine tumors.

GEO: GSE1037

91 × 40233

(91 × 39746)

Patients with (72) and without (19) cancer.

Sørlie [18]

Human breast carcinomas.

http://genome-www.stanford.edu/breast_cancer/mopo_clinical/data/mopo_clinical.gz.tar

73 × 8033

(73 × 7734)

Clinical ER-status ER+ (55), ER- (18)

Ye [19]

Samples from 40 hepatitis B-positive patients with hepatocellular carcinoma (HCC).

GEO: GSE364

87 × 8911

metastatic (P) and non-metastatic (PN) patients. P (65), PN (22)